PE Tech Report


Like this article?

Sign up to our free newsletter

Radiology technology start-up Hexarad raises further £2.2m to complete Series A funding

Radiology technology start-up Hexarad has completed its Series A funding round with an additional raise of £2.2 million led by Foresight Group. This is in addition to £2.3 million Hexarad raised in 2021, bringing the full raise to £4.5 million. 

Foresight Group also invested in 2021, while additional angel investors including healthcare leaders Sachin Agrawal based in the US and Henry Carleton based in the UK, also participated in this latest round.

Hexarad is an early stage, high growth healthcare technology company, providing technology-driven solutions to boost radiology capacity and address the key causes of diagnostic delays. Headquartered in London, Hexarad was founded in 2016 by a group of NHS consultant radiologists. Since 2016, Hexarad has grown rapidly and is now a major provider to both the NHS and private healthcare customers.

The additional funding raised through this round will allow Hexarad to continue to grow its radiology platform which focuses on allocative efficiency to improve scan reporting times.

Like this article? Sign up to our free newsletter